-       Report 
- March 2025
-  57 Pages 
- France 
   From       €4468EUR$4,995USD£3,930GBP 
          -       Report 
- March 2025
-  52 Pages 
- Canada 
   From       €4468EUR$4,995USD£3,930GBP 
          -       Report 
- June 2024
-  179 Pages 
- Global 
   From       €3578EUR$4,000USD£3,147GBP 
          -       Report 
- September 2023
-  31 Pages 
- North America 
   From       €3573EUR$3,995USD£3,143GBP 
          -       Report 
- September 2023
-  39 Pages 
- Europe 
   From       €3573EUR$3,995USD£3,143GBP 
           -       Report 
- September 2023
-  39 Pages 
- Asia Pacific 
   From       €3573EUR$3,995USD£3,143GBP 
          -       Report 
- August 2023
-  17 Pages 
- India 
   From       €2679EUR$2,995USD£2,356GBP 
          -       Report 
- August 2023
-  17 Pages 
- Germany 
   From       €2679EUR$2,995USD£2,356GBP 
          -       Report 
- August 2023
-  17 Pages 
- Canada 
   From       €2679EUR$2,995USD£2,356GBP 
          -       Report 
- August 2023
-  17 Pages 
- Australia 
   From       €2679EUR$2,995USD£2,356GBP 
          -       Report 
- November 2021
-  51 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- October 2024
-  93 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- March 2024
-  322 Pages 
- United States 
   From       €7151EUR$7,995USD£6,290GBP 
          -       Report 
- March 2023
-  112 Pages 
- Global 
   From       €4468EUR$4,995USD£3,930GBP 
          -       Report 
- March 2023
-  648 Pages 
- Global 
   From       €8940EUR$9,995USD£7,864GBP 
          -       Report 
- November 2022
-  150 Pages 
- Global 
   From       €4338EUR$4,850USD£3,816GBP 
          -       Report 
- November 2024
-  95 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- November 2024
-  99 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- November 2024
-  84 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- November 2024
-  95 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
       
      The Spinal Cord Stimulator (SCS) is a type of medical device used to treat chronic pain in the lower back, neck, and limbs. It works by sending electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain. SCS is a form of neuromodulation, which is a type of therapy that uses electrical stimulation to modify nerve activity. It is used to treat a variety of conditions, including failed back surgery syndrome, complex regional pain syndrome, and peripheral neuropathy.
SCS    is a minimally invasive procedure, and is typically used when other treatments have failed. It is typically implanted in the lower back, and is connected to a small battery-powered device that is worn externally. The device is programmed to deliver electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain.
The SCS market is a growing segment of the neurology devices market. It is expected to continue to grow as more patients seek out minimally invasive treatments for chronic pain.
Some companies in the SCS market include Medtronic, Boston Scientific, St. Jude Medical, and Nevro. Show Less   Read more